List of Tables
Table 1. Hospital Acquired Urinary Tract Infection Market Trends
Table 2. Hospital Acquired Urinary Tract Infection Market Drivers & Opportunity
Table 3. Hospital Acquired Urinary Tract Infection Market Challenges
Table 4. Hospital Acquired Urinary Tract Infection Market Restraints
Table 5. Global Hospital Acquired Urinary Tract Infection Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hospital Acquired Urinary Tract Infection Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hospital Acquired Urinary Tract Infection Product Type
Table 9. Key Companies Time to Begin Mass Production of Hospital Acquired Urinary Tract Infection
Table 10. Global Hospital Acquired Urinary Tract Infection Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Urinary Tract Infection as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hospital Acquired Urinary Tract Infection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hospital Acquired Urinary Tract Infection Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hospital Acquired Urinary Tract Infection Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hospital Acquired Urinary Tract Infection Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hospital Acquired Urinary Tract Infection Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hospital Acquired Urinary Tract Infection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hospital Acquired Urinary Tract Infection Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hospital Acquired Urinary Tract Infection Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hospital Acquired Urinary Tract Infection Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hospital Acquired Urinary Tract Infection Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hospital Acquired Urinary Tract Infection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hospital Acquired Urinary Tract Infection Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hospital Acquired Urinary Tract Infection Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hospital Acquired Urinary Tract Infection Sales Value by Region (2019-2024) & (%)
Table 27. Global Hospital Acquired Urinary Tract Infection Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hospital Acquired Urinary Tract Infection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hospital Acquired Urinary Tract Infection Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hospital Acquired Urinary Tract Infection Sales Value, (2025-2030) & (US$ Million)
Table 31. Advanced Sterilization Products Basic Information List
Table 32. Advanced Sterilization Products Description and Business Overview
Table 33. Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Advanced Sterilization Products (2019-2024)
Table 35. Advanced Sterilization Products Recent Developments
Table 36. Becton Basic Information List
Table 37. Becton Description and Business Overview
Table 38. Becton Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Becton (2019-2024)
Table 40. Becton Recent Developments
Table 41. Dickinson and Company Basic Information List
Table 42. Dickinson and Company Description and Business Overview
Table 43. Dickinson and Company Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Dickinson and Company (2019-2024)
Table 45. Dickinson and Company Recent Developments
Table 46. Steris Corporation Basic Information List
Table 47. Steris Corporation Description and Business Overview
Table 48. Steris Corporation Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Steris Corporation (2019-2024)
Table 50. Steris Corporation Recent Developments
Table 51. Getinge Group Basic Information List
Table 52. Getinge Group Description and Business Overview
Table 53. Getinge Group Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Getinge Group (2019-2024)
Table 55. Getinge Group Recent Developments
Table 56. Kimberly-Clark Corporation Basic Information List
Table 57. Kimberly-Clark Corporation Description and Business Overview
Table 58. Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Kimberly-Clark Corporation (2019-2024)
Table 60. Kimberly-Clark Corporation Recent Developments
Table 61. Cantel Medical Basic Information List
Table 62. Cantel Medical Description and Business Overview
Table 63. Cantel Medical Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Cantel Medical (2019-2024)
Table 65. Cantel Medical Recent Developments
Table 66. Biomerieux Basic Information List
Table 67. Biomerieux Description and Business Overview
Table 68. Biomerieux Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Biomerieux (2019-2024)
Table 70. Biomerieux Recent Developments
Table 71. Belimed Basic Information List
Table 72. Belimed Description and Business Overview
Table 73. Belimed Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Belimed (2019-2024)
Table 75. Belimed Recent Developments
Table 76. 3M Company Basic Information List
Table 77. 3M Company Description and Business Overview
Table 78. 3M Company Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of 3M Company (2019-2024)
Table 80. 3M Company Recent Developments
Table 81. Sterigenics International Basic Information List
Table 82. Sterigenics International Description and Business Overview
Table 83. Sterigenics International Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Sterigenics International (2019-2024)
Table 85. Sterigenics International Recent Developments
Table 86. Synergy Health Basic Information List
Table 87. Synergy Health Description and Business Overview
Table 88. Synergy Health Hospital Acquired Urinary Tract Infection Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hospital Acquired Urinary Tract Infection Business of Synergy Health (2019-2024)
Table 90. Synergy Health Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Hospital Acquired Urinary Tract Infection Downstream Customers
Table 94. Hospital Acquired Urinary Tract Infection Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hospital Acquired Urinary Tract Infection Product Picture
Figure 2. Global Hospital Acquired Urinary Tract Infection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hospital Acquired Urinary Tract Infection Sales Value (2019-2030) & (US$ Million)
Figure 4. Hospital Acquired Urinary Tract Infection Report Years Considered
Figure 5. Global Hospital Acquired Urinary Tract Infection Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hospital Acquired Urinary Tract Infection Revenue in 2023
Figure 7. Hospital Acquired Urinary Tract Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Microbial Testing Instruments Picture
Figure 9. Reagents and Consumables Picture
Figure 10. Infection Prevention and Surveillance Software Picture
Figure 11. Global Hospital Acquired Urinary Tract Infection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Hospital Acquired Urinary Tract Infection Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Disease Testing
Figure 14. Product Picture of Drug-resistance Testing
Figure 15. Global Hospital Acquired Urinary Tract Infection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Hospital Acquired Urinary Tract Infection Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Hospital Acquired Urinary Tract Infection Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Hospital Acquired Urinary Tract Infection Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Hospital Acquired Urinary Tract Infection Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Hospital Acquired Urinary Tract Infection Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Hospital Acquired Urinary Tract Infection Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Hospital Acquired Urinary Tract Infection Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Hospital Acquired Urinary Tract Infection Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Hospital Acquired Urinary Tract Infection Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Hospital Acquired Urinary Tract Infection Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Hospital Acquired Urinary Tract Infection Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Hospital Acquired Urinary Tract Infection Sales Value (%), (2019-2030)
Figure 28. United States Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 34. China Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 36. China Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 46. India Hospital Acquired Urinary Tract Infection Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Hospital Acquired Urinary Tract Infection Sales Value by Type (%), 2023 VS 2030
Figure 48. India Hospital Acquired Urinary Tract Infection Sales Value by Application (%), 2023 VS 2030
Figure 49. Hospital Acquired Urinary Tract Infection Industrial Chain
Figure 50. Hospital Acquired Urinary Tract Infection Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
